A Recap of the ALMS-SL collaborative Workshop and screening with Thinking Pink Breast Cancer Foundation 🩷. #Breastcanceraweness. #ALMS-SL
-
-
-
-
-
+1
Association of Laboratory Medicine Students - Sierra Leone (ALMS-SL)’s Post
More Relevant Posts
-
In honour of pancreatic cancer awareness month, you can read up on Garvan's recent promising new discoveries for this aggressive cancer. Click here: https://ow.ly/Ro7750U9BWi
-
-
New in Clinical Cancer Research: A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study. https://bit.ly/3OQ6G2x #SABCS24
-
-
📜Check out the #Review "HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept" ✍by Yanjun Hou (Atrium Health Wake Forest Baptist) et al. Find the full paper here▶️ https://lnkd.in/dN_aKtuE Keywords: HER2; breast cancer; heterogeneity
-
-
These orthotopic models of NSCLC tumors are pivotal for testing new therapies and understanding resistance mechanisms. Kudos to Ulrich Jarry, Remy Pedeux and the team for their valuable contribution to lung cancer research! 🧬💊 #oncotrial #LungCancerResearch #CancerTherapies #PreclinicalModels #NSCLC #BiomedicalResearch #OncologyResearch https://lnkd.in/d_3J5zJy
-
-
Key highlights you should know from this year's World Conference on Lung Cancer 👉 https://bit.ly/wclc2024 Earlier this month, the Outcomes4Me team was at the #WCLC24 in San Diego. Explore some of the emerging research in lung cancer that we learned from this global conference. #NSCLC #NCCNLung #DigitalHealth #PatientAdvocacy
-
-
In collaboration with Repare Therapeutics, our novel work here demonstrates the efficacy of novel cell cycle target-PKYMT1 using a selective inhibitor RP-6306 and future combinations in tumors with high Cyclin expression. MYTHIC trial (https://lnkd.in/gBD5nmTM)
A study led by our Dr. Khandan Keyomarsi highlights the therapeutic potential of PKMYT1 inhibitors for patients with triple-negative breast cancer. Learn about this and other new MD Anderson research. #CancerResearch #EndCancer
-
Don't forget, ABC8 is exactly one year away! ABC8 is a bi-annual Advanced Breast Cancer International Consensus Conference has the goal to formulate international consensus guidelines for the optimal management of advanced breast cancer (ABC). Add it to your calendar! https://lnkd.in/gxvfP_y7
-
-
https://cnn.it/40Xvh Our very own Ludmil Alexandrov was featured on @CNN's interview about "How an AI Program Could Personalize Breast and Ovarian Cancer Care" #stemcells #cancer #UCSD #UCSanDiego #breastcancer #ovariancancer
-
📖 Fumiko Chino, MD, spoke about the recently published study linking talcum powder to ovarian cancer. Read the full interview here ⬇️ https://lnkd.in/ekrKgHfs #gyncsm #cancer #oncology
-